Mabtech Establishes Strategic U.S. Collaboration with Sai Life Sciences to Expand Access to EYRA™ Multiplex Immunology Platform

Mabtech, a Swedish life science tools company specializing in high-quality immunoassays, reagents, and instrumentation, today announced a strategic collaboration with Sai Life Sciences, a leading ...
PE Hub

EQT takes Mabtech in first acquisition of new strategy

Biotech is our opening topic this morning as we deep dive into a double announcement from EQT. The firm is acquiring a Swedish biotech company as part of the launch of a new Healthcare Growth Strategy ...

ELISpot & FluoroSpot Assay Market Report 2026-2031: Mabtech, Oxford Immunotec Global, and Cellular Technology Dominate the Landscape

The "ELISpot & FluoroSpot Assay Market Report: Trends, Forecast and Competitive Analysis to 2031" has been added to ResearchAndMarkets.com's offering. The global ELISpot & FluoroSpot assay market is ...
Taiwan News

Mabtech and Sai Life Sciences Announce Strategic Collaboration to Advance Immunology Research with EYRA Platform at Sai Boston Site

BOSTON and STOCKHOLM, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Mabtech, a global life science tools company specializing in advanced immunoassays, and Sai Life Sciences, a leading integrated Contract ...
Pharmabiz

Mabtech, Sai Life Sciences partner to advance immunology research with EYRA platform at Sai Boston site

Mabtech, a global life science tools company specializing in advanced immunoassays, and Sai Life Sciences, a leading integrated contract research, development, and manufacturing organization (CRDMO), ...